Oliver Boris Stauch

Title: The Innovations of Oliver Boris Stauch

Introduction

Oliver Boris Stauch, located in Freiburg, Germany, is a prolific inventor renowned for his work in the field of biopharmaceuticals. With a total of 10 patents to his name, Stauch has made significant contributions to the formulation of antibody therapies, particularly in overcoming challenges related to stability and storage.

Latest Patents

Among Stauch's latest patents is a high concentration antibody-containing liquid formulation aimed at providing a humanized anti-IL-6 receptor antibody (AMA) suitable for subcutaneous administration. This formulation addresses critical issues such as preventing dimerization or deamidation during long-term storage. The application provides a stable liquid formulation characterized by the incorporation of arginine and a histidine buffer. Another noteworthy patent focuses on a similar formulation for a humanized anti-IL-6 receptor antibody (MRA), showcasing Stauch's expertise in biopharmaceutical innovations and his commitment to enhancing patient treatment options.

Career Highlights

Throughout his career, Stauch has held positions at prestigious companies including Chugai Seiyaku Kabushiki Kaisha and Genentech, Inc. His work in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in antibody formulations and therapeutic strategies.

Collaborations

Stauch has collaborated with esteemed colleagues such as Toshiyuki Morichika and Daisuke Kameoka. These partnerships have facilitated the exchange of ideas and expertise, further enriching the field of antibody research and development.

Conclusion

With his innovative spirit and dedication to finding solutions in biopharmaceutical formulations, Oliver Boris Stauch continues to influence the landscape of medical treatment through his patents and collaborative efforts. His work not only reflects his individual accomplishments but also contributes to broader advancements in the healthcare sector.